Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Excelsior Diagnostics is a private healthcare diagnostics company operating clinical laboratory and mobile testing services in the United States. Publicly available information indicates the company provides PCR-based molecular testing focused on infectious disease detection and antibiotic-resistance-related laboratory analysis, alongside employer and agency testing services such as on-site mobile testing and compliance-oriented screening. The company appears to operate through an active Florida legal entity and has also been associated with a Houston laboratory presence and the trade name Apex Molecular or Apex Molecular Labs. Based on the available evidence, it is a commercial-stage diagnostics services business rather than a therapeutic drug developer. There is no clear evidence of a drug pipeline, clinical-stage therapeutic assets, or public-market listing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Excelsior Diagnostics.